Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic similarity study of levodopa/carbidopa [ND0612H] to Duodopa in healthy volunteers

Trial Profile

Pharmacokinetic similarity study of levodopa/carbidopa [ND0612H] to Duodopa in healthy volunteers

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 Mar 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Acronyms Trial 009
  • Most Recent Events

    • 01 Mar 2017 According to NeuroDerm media release, based on minutes from a meeting held in January 2017 with the EMA and the preliminary results of trial 006 (CT profile 261957), company has modified its EU clinical and regulatory development path. The modified strategy will be based on restarted and amended iNDiGO trial (CT profile 252739), rather than on bioequivalent pharmacokinetic (PK) studies. Hence this study will not be carried out.
    • 01 Mar 2017 Status changed from planning to discontinued, according to a NeuroDerm media release.
    • 25 Aug 2016 According to a NeuroDerm media release, this trial is expected to initiate at the end of 2016 or beginning of 2017.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top